Erythrocytes maintained in vitro under controlled conditions at pH 7·40 were unable to respond to changes in extracellular phosphate concentrations with changes in intracellular 2,3-bisphosphoglycerate content over an 8 h incubation period. Increased extracellular phosphate concentrations did not retard the rate at which 2,3-bisphosphoglycerate concentrations fell when erythrocytes were incubated at pH 7·10. Elevated extracellular phosphate concentrations did not increase the rate of recovery of intracellular 2,3-bisphosphoglycerate concentrations when erythrocytes were returned to pH 7·40 having been incubated at pH 7·10. The rate at which 2,3-bisphosphoglycerate concentrations increased under these latter conditions was too slow to counterbalance any effect that adjustment of blood pH may have on the position of the haemoglobin–oxygen dissociation curve during treatment of diabetic ketoacidosis.
References
1.
AlbertiKGMMDarleyJHEmersonPM2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet1972; ii: 391–5.
2.
KanterYGersonJRBessmanAN. 2,3-Diphosphoglycerate, nucleotide phosphate, and organic and inorganic phosphate levels during the early phases of diabetic ketoacidosis. Diabetes1977; 26: 429–33.
3.
BeneschREBeneschR.The mechanism of interaction of red cell organic phosphates with hemoglobin. Adv Protein Chem1974; 28: 211–37.
4.
DitzelJStandiE.The oxygen transport system of red blood cells during diabetic ketoacidosis and recovery. Diabetologia1975; 11: 255–60.
5.
DitzelJStandiE.The problem of tissue oxygenation in diabetes mellitus II. Evidence of disordered oxygen release from the erythrocytes of diabetics in various conditions of metabolic control. Acta Med Scand Suppl1975; 578: 59–68.
6.
DitzelJ.Effect of plasma inorganic phosphate on tissue oxygenation during recovery from diabetic ketoacidosis. Adv Exp Med Biol1973; 37: 163–72.
7.
KellerUBergerW.Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Diabetes1980; 29: 87–95.
8.
WilsonHKKeuerSPLeaASPhosphate therapy in diabetic ketoacidosis. Arch Intern Med1982; 142: 517–20.
9.
LichtmanMAMillerDRCohenJReduced red cell glycolysis, 2,3-diphosphoglycerate and adenosine triphosphate concentration, and increased hemoglobin-oxygen affinity caused by hypophosphatemia. Ann Intern Med1971; 74: 562–8.
10.
GerberGHolzhutterHRoselerR2,3-biphosphoglycerate, inorganic phosphate, pH and hemoglobin concentration in chronic renal failure of man. Acta Biol Med Germ1981; 40: 711–15.
11.
Alvarez-SalaJLUrbanMASiciliaJJRed-cell 2,3-diphosphoglycerate in patients with hyperthyroidism. Acta Endocrinol1980; 93: 424–9.
12.
LichtmanMAMurphyMSByerBJHemoglobin affinity for oxygen in chronic renal disease: The effect of hemodialysis. Blood1974; 43: 417–24.
13.
MacdonaldRGuillouPJKesterRC. Plasma phosphate and red cell 2,3-diphosphoglycerate following abdominal surgery. Anaesthesia1980; 35: 339–44.
14.
YoungJALichtmanMACohenJ.Reduced red cell 2,3-diphosphoglycerate and adenosine triphosphate, hypophosphatemia, and increased hemoglobin-oxygen affinity after cardiac surgery. Circulation1973; 47: 1313–18.
15.
TsuboiKKFukunagaK.Inorganic phosphate and enhanced glucose degradation by intact erythrocytes. J Biol Chem1965; 240: 2806–10.
16.
RoseIAWarmsJVB. Control of red cell glycolysis. The cause of triose phosphate accumulation. J Biol Chem1970; 245: 4009–15.
17.
BrainMCCardRT. Effect of inorganic phosphate on red cell metabolism: in vitro and in vivo studies. Adv Exp Med Biol1972; 28: 145–54.
18.
BellinghamAJDetterJCLenfantC.Regulatory mechanisms of hemoglobin oxygen affinity in acidosis and alkalosis. J Clin Invest1971; 50: 700–6.
19.
RoseZBLiebowitzJ.2,3-diphosphoglycerate phosphatase from human erythrocytes. General properties and activation by anions. J Biol Chem1970; 245: 3232–41.
20.
RoseZB. The enzymology of 2,3-bisphosphoglycerate. Adv Enzymol1980; 51: 211–53.
21.
NygaardSFRorthM.An enzymatic assay of 2,3-diphosphoglycerate in blood. Scand J Clin Lab Invest1969; 24: 399–403.
22.
KimmichGARandiesJBrandJS. Assay of picomole amounts of ATP, ADP, and AMP using the luciferase enzyme system. Anal Biochem1975; 69: 187–206.
23.
BeutlerE. In: Red Cell Metabolism: A Manual of Biochemical Methods. London and New York: Grune and Stratton, 1971; 109–10.
24.
FiskeCHSubbaRowY.Colorimetric determination of phosphorus. J Biol Chem1925; 66: 375–400.
25.
RyallRGStoryCJ. An equilibrium model of the oxygen association curve of normal human erythrocytes under standardized conditions. Clin Chem1983; 29: 1819–22.
26.
SchnellKFBeslEvan der MoselR.Phosphate transport in human red blood cells: Concentration dependence and pH dependence of the unidirectional phosphate flux at equilibrium conditions. J Membrane Biol1981; 61: 173–92.
27.
GibbyOMVealeKEAHayesTMOxygen availability from the blood and the effect of phosphate replacement on erythrocyte 2,3-diphosphoglycerate and haemoglobin-oxygen affinity in diabetic ketoacidosis. Diabetologia1978; 15: 381–5.
28.
OskiFATravisSFMillerLDThe in vitro restoration of red cell 2,3-diphosphoglycerate levels in banked blood. Blood1971; 37: 52–8.
29.
SugermanHVPollockTWRosatoEFExperimentally induced alterations in affinity of hemoglobin for oxygen II. In vivo effect of inosine, pyruvate and phosphate oxygen-hemoglobin affinity in Rhesus monkey. Blood1972; 39: 525–9.
30.
RodriquezJMShahidiNT. Erythrocyte 2,3-diphosphoglycerate in adaptive red-cell volume deficiency. New Engl J Med1971; 285: 479–82.
31.
BoningDMeierUSkipkaWSome evidence for aldosterone action on 2,3-diphosphoglycerate level in human red cells. Metabolism1976; 25: 9–14.
